<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="118926">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01554748</url>
  </required_header>
  <id_info>
    <org_study_id>2012-01</org_study_id>
    <nct_id>NCT01554748</nct_id>
  </id_info>
  <brief_title>Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint</brief_title>
  <official_title>Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates implant survival in total joint arthroplasty of the Trapeziometacarpal
      (TMC) joint by monitoring the survival of different implant types using radiostereometry
      (RSA) evaluation of the implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study evaluates implant survival and clinical outcome in total joint arthroplasty of the
      TMC joint. Different implant designs are included in the study both cemented and uncemented
      implants. Also the influence of patient factors and surgical technique on implant survival
      is investigated. The primary outcome is implant migration and loosening. Evaluation is done
      by monitoring migration and loosening of different implant types using RSA evaluation of the
      implants. Secondary outcomes are patient reported function evaluated with the Disability of
      the arm, shoulder and hand score (DASH) and visual analog pain score (VAS). Tertiary outcome
      is range of movement (ROM) plus grip strength.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>10 year survival</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>implant fixation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>implant fixation with different techniques</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>implant fixation with different techniques and designs</intervention_name>
    <description>implant fixation cemented/uncemented</description>
    <arm_group_label>implant fixation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Eaton type 2+3 TMC osteoarthritis

        Exclusion Criteria:

          -  Patients with Eaton type 4 TMC osteoarthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torben B. Hansen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Research Unit Regional Hospital Holstebro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Orthopaedics, Regional Hospital Holstebro</name>
      <address>
        <city>Holstebro</city>
        <zip>DK-7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torben B. Hansen, MD, PhD</last_name>
      <email>torbehns@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Torben B. Hansen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 18, 2015</lastchanged_date>
  <firstreceived_date>March 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regional Hospital Holstebro</investigator_affiliation>
    <investigator_full_name>Torben B. Hansen</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>total joint arthroplasty</keyword>
  <keyword>thumb</keyword>
  <keyword>trapeziometacarpal joint</keyword>
  <keyword>osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
